中国血液净化 ›› 2025, Vol. 24 ›› Issue (12): 1017-1021.doi: 10.3969/j.issn.1671-4091.2025.12.011

• 血液净化中心管理 • 上一篇    下一篇

基于专利数据的全球血液透析技术发展态势及我国发展对策研究

苏建明    骆 静   

  1. 610213 成都,国家知识产权局专利局专利审查协作四川中心1电学发明审查部 2光电技术发明审查部
  • 收稿日期:2025-03-31 修回日期:2025-09-29 出版日期:2025-12-12 发布日期:2025-12-12
  • 通讯作者: 骆静 E-mail:luojing.cq@126.com

Research on the Development Trend of Global Hemodialysis Technology Based on Patent Data and the Development Countermeasures in China

SU Jian-ming, LUO Jing   

  1. Patent Examination Department of Electrical Engineering, 2Patent Examination Department of Optoelectronic Technology, Patent Examination Cooperation Sichuan Center of the Patent Office, Chengdu 610213, China
  • Received:2025-03-31 Revised:2025-09-29 Online:2025-12-12 Published:2025-12-12
  • Contact: 610213 成都,国家知识产权局专利局专利审查协作四川中心2光电技术发明审查部 E-mail:luojing.cq@126.com

摘要: 目的 从专利角度揭示血液透析技术国内外研究态势,比较国内外技术差异,为我国企业技术突破及专利布局提供参考。  方法   基于全球专利数据,从专利申请态势、申请人分布等维度分析,对透析膜、透析液、监测报警等核心技术的发展和演进进行研究。 结果  我国专利申请量逐年增长,在缓慢增长阶段、振荡增长阶段和快速增长阶段的年平均增长率为19.74%、30.48%、33.56%;国外专利申请从2017年开始逐渐降低(2017—2021年增长率为-2.01%)。我国有3名申请人进入全球专利申请人前20,我国38%的专利申请来自企业,33%的专利申请来自医院。透析膜重点发展方向为膜的材料、成型工艺及功能化;透析液专利技术集中在个性化调节,以及依据不同个体添加治疗性药物;透析液供给及加热技术聚焦于智能化、安全性。  结论  我国已从技术追随者成长为推动全球血液透析技术发展的重要力量,具有临床机构与企业协同创新优势。

关键词: 血液透析, 专利分析, 国产化替代, 专利布局

Abstract: Objective  This paper aims to reveal the domestic and international research trends in hemodialysis technology from the perspective of patents, to compare the technological differences between domestic and foreign technologies, and to provide references for technological breakthroughs and patent layout of domestic enterprises.  Methods   Based on global patent data, the analysis is conducted from the dimensions of application trends, and applicant distribution. The development and evolution of core technologies such as dialysis membranes, dialysis fluids, and monitoring alarms are also studied.  Results  The annual average growth rates of domestic patent applications during the slow growth, oscillating growth, and rapid growth phases were 19.74%, 30.48%, and 33.56%, respectively. In contrast, foreign applications began to decline gradually starting in 2017 (The annual average growth rate from 2017 to 2021 was -2.01%). Three domestic applicants ranked among the top 20 global patent applicants. Domestically, 38% of patent applications originated from enterprises, while 33% came from hospitals. The key development directions for dialyzer membranes focus on membrane materials, forming processes, and functionalization. Patent technologies for dialysate concentrate on personalized regulation and the addition of therapeutic drugs tailored to different individuals. Dialysate delivery and heating technologies focus on intelligence and safety.  Conclusions  Domestic entities have evolved from technology followers into a significant force driving the global development of hemodialysis technology. The domestic landscape possesses the advantage of collaborative innovation between clinical institutions and enterprises.

Key words: Hemodialysis, Patent analysis, Domestic substitution, Patent layout 

中图分类号: